CareCloud shares surge 15.93% premarket after raising 2025 revenue guidance, completing Medsphere acquisition, and accelerating AI initiatives.

CareCloud surged 15.93% in premarket trading following the release of strong Q3 2025 results, including a 9% year-over-year revenue increase, six consecutive quarters of GAAP net income, and a raised full-year revenue guidance to $117–$119 million. The company highlighted successful integration of the Medsphere acquisition, which expanded its hospital IT footprint, and progress in its AI Center of Excellence, enhancing operational efficiency and cross-selling opportunities. Management emphasized disciplined execution, debt reduction (lowering line-of-credit borrowing to $4.9 million), and continued monthly preferred stock dividends funded by free cash flow. The strategic focus on AI-driven innovation, recent acquisitions, and improved profitability aligned with the stock’s sharp premarket rise, reflecting investor optimism about CareCloud’s growth trajectory in healthcare technology.